11-(クロロアセチル)-5,11-ジヒドロ-6H-ピリド[2,3-b][1,4]ベンゾジアゼピン-6-オン5,11-ジヒドロ-11-クロロアセチル-6H-ピリド[2,3-B][1,4]ベンゾジアゼピン-6-オン2-(2-クロロアセチル)-2,4,9-トリアザトリシクロ[9.4.0.03,8]ペンタデカ-1(15),3,5,7,11,13-ヘキサエン-10-オンdcpboPirenzepine EP Impurity AN'-(2-chloro-3-pyridinyl)-N,N-dimethylmethanimidamide11-(chloroacetyl)-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodia...11-(CHLOROACETYL)-5,11-DIHYDRO-6H-PYRIDO[3,2-C][2]BENZAZEPIN-6-ONE5,11-Dihydro-11-Chloroacetyl-6H-Pyrido[2,3-B][1,4]Benzodiazepin-6-One5,11-DIHYDRO-11-CHLOROACETYL-6H-PYRIDOP2,3-B][1,4]BENZODIAZEPINE-6-ONE1-(2-Chloroacetyl)-5,11-dihydro-pyrido-[2,3-b][1,4]benzodiazepin-6-one
H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]
P261, P264+P265, P272, P280, P302+P352, P305+P351+P338, P321, P333+P317, P337+P317, P362+P364, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 4 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.